Category: PrimeCuts

Commentary by Sean Cavanaugh MD, Associate Editor, Clinical Correlations

We start this week’s Shortcuts with the cheery news that another drug is being investigated for a possible association with mood disorder and suicidality. First …

Commentary by Henry Tran MD

The seasons of the year, like governors of New York, change quickly. And with that, we welcome the new spring, a time of rebirth and renewal!

Well sticking …

Commentary by Josh Olstein MD, Associate Editor, Clinical Correlations

Let’s begin this St. Patrick’s Day edition of ShortCuts with a look across the pond. An article published in this week’s edition of The Lancet …

Commentary by Cara Litvin MD, Executive Editor, Clinical Correlations 

Vaccines were the buzz this week after it was made public that a federal government program designed to compensate people after vaccine injuries agreed to compensate …

Commentary by Judith Brenner MD, Associate Program Director, NYU Internal Medicine Residency Program

There were many medical stories in the news last week that seemed relevant and worthy of a spot in this week’s ShortCuts. First, …

Commentary by Danise Schiliro-Chuang MD, NYU Chief Resident 

Hello and welcome to this week’s shortcuts. Let’s jump right to what’s new in the journals.

Two large, multicenter, randomized controlled studies published in the February 13 …

Commentary by Michael Poles MD, Associate Editor, Clinical Correlations 

Welcome back blogophiles to this week’s clinical correlations. Hope you all had a nice President’s Day weekend. Now, let’s move on to the discussion.

Read More

Commentary by Aaron Lord MD, Copy Editor, Clinical Correlations

The medical news event of the week was of course the early termination of the glucose control arm of the ACCORD trial, which showed increased …